Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/VAXART-INC-40834288/attualita/Vaxart-Inc-annuncia-i-dati-preliminari-positivi-dello-studio-di-Fase-2-con-estensione-della-dose-d-44310444/?utm_source=whatsapp&utm_medium=social&utm_campaign=share